[Treatment of diabetes mellitus--with special reference to the treatment of insulin-resistant diabetes with proteolytic enzymes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D002918:Chymotrypsin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003964:Diaphragm / Q000378:metabolism; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D006029:Glycosuria; D006801:Humans; D007106:Immune Sera; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D007330:Insulin Antibodies; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D051381:Rats
D001786:Blood Glucose; D001798:Blood Proteins; D007106:Immune Sera; D007328:Insulin; D007330:Insulin Antibodies; D010450:Endopeptidases; D002918:Chymotrypsin